Skip to content

Translation and Validation of the Thai Version of the Nasal Obstruction Symptom Evaluation (NOSE) Scale

Translation and Validation of the Thai Version of the Nasal Obstruction Symptom Evaluation (NOSE) Scale

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20220706006
Enrollment
105
Registered
2022-07-06
Start date
2021-04-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasal septal deviation with clinical chronic nasal airway obstruction lasting at least 3 months Deviated nasal septum Nasal airway obstruction NOSE Questionnaire Validation

Interventions

patients with diviated nasal septum and clinical nasal airway obstruction more than three months,healthy asymptomatic volunteers
Screening,Screening
Nasal airway obstruction ,Control

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: . The first group consisted of patients who were able to read and speak Thai, were aged at least 18 years old, who had nasal septal deviation with clinical chronic nasal airway obstruction lasting at least 3 months, and who had persistent symptoms after 4 weeks of medication (tropical nasal steroid, decongestants, oral antihistamine). The diagnosis was performed using rigid endoscopy or CT scans.

Exclusion criteria

Exclusion criteria: sinonasal malignancy, previous or ongoing radiation therapy of the head and neck, previous septoplasty, rhinoplasty or turbinoplasty, a history or clinical evidence of chronic sinusitis, nasal septal perforation, craniofacial syndrome, nasal trauma or fracture in the past 3 months, nasal valve collapse, adenoid hypertrophy, sarcoidosis, Wegener granulomatosis, uncontrolled asthma, or pregnancy

Design outcomes

Primary

MeasureTime frame
Validity (construct) 14 days after initial test Inter-item and each item-total score were calculted and reported with Spearmans rho and p-value,Validity (discriminant) 14 days after initial test Total scores of each item between study patients and control group were calculted and reported with the independent t test and p-value,Internal Consistency 14 days after initial test Total scores between study patients and control group were calculted and reported with Cronbachs alpha coefficients,Test-Retest Reliability 14 days after initial test Scores from the initial test and retest of both groups were calculted and reported with Goodman-Kruskal gamma coefficient, paired t tests and p-value

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public ContactKanokpon Prasertwit

University Hospital

basuka_bas@windowslive.com0987465389

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026